Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

BORIO LUCIANA

STONESIFER TIMOTHY C.

MINOGUE MICHAEL R

McEvoy Ashley

Frederick Wayne A.I.

Cousin Laetitia

Singh Prem

Benjamin Eric

Instividual Trader/Investor   https://t.co/6XxJw5gfQN

** INFORMATIONAL PURPOSES ONLY *DO NOT TRADE OFF ANY OF MY INFORMATION**

Insulet Corporation (PODD) Stock Price, Analysis & Trade Signals